(Nanowerk Spotlight) Precision in drug delivery has long posed a significant challenge to the medical field. Relying on the body’s circulatory system to transport medications often results in inefficient drug distribution, with only a fraction of the intended dose reaching the target area. This inefficiency forces higher doses to be administered, leading to harmful side effects as excess medication interacts with healthy tissues. Despite gradual improvements, traditional methods of drug delivery are still constrained by these limitations, pushing researchers to develop more controlled and precise systems.
Recent technological advances are making this more achievable. Miniature soft robots, capable of navigating the body and dispensing drugs with precision, are emerging as a powerful alternative to traditional drug delivery systems. These tiny machines offer new ways to target specific disease sites while minimizing the side effects associated with conventional treatments. However, most existing soft robots are limited in their ability to deliver multiple medications with adjustable dosage and sequence, crucial for complex therapies like cancer treatment.
Unlike previous models that could carry only one or two drugs, this new robot can transport four different medications, releasing each in a programmable sequence and adjustable dosage. This technology opens the door to more effective combination therapies, where multiple drugs need to be delivered in a highly specific manner to achieve the best therapeutic outcomes.
A miniature soft robot that can carry four distinct drugs, and reprogram its drug-dispensing sequence and dosage. A) The configuration of the proposed soft robot. (i) An auxiliary view of soft robot, which shows that it has four drug modules and a pair of soft tentacles. Each drug module carries a distinct drug, that is, the drugs in modules I, II, III, and IV are green, orange, blue, and purple, respectively. Drugs I-IV are defined as the drugs carried by their respective drug module. ii) The side view of the soft robot where the auxiliary magnet is between the drug modules and the soft tentacles, and its magnetic moment is parallel to m. The magnetization profile of the soft tentacles is shown to be symmetrical. By having this magnetization profile, the soft tentacles can deform into an inverted “U”-shaped configuration, and the soft robot’s m is always parallel to the applied B. The local coordinate frame of the soft robot is also shown here. The red semi-circle outline is used as a reference for the soft robot’s orientation. B) The top view of a drug module. (i) Each drug module has a pair of identical magnetic vibrating beams and valves with one opening. (ii) When the magnetic vibrating beams are subjected to a designated, alternating B of selected f and Bamp, they will vibrate and strike the valve in the module to eject the drugs. The red semi-circle outline corresponds to that of (A).
The robot’s key feature is its actuation by alternating magnetic fields. These fields allow the robot to move through the body and dispense drugs at precise locations. Its six degrees of freedom (6-DOF) in motion enable it to navigate through complex, unstructured environments inside the human body—a critical capability given that many disease sites, such as tumors, are often located in hard-to-reach areas. The dexterity provided by this 6-DOF motion makes it significantly more versatile than existing robots, which often struggle to overcome the physical obstacles present within the body.
One of the standout features of this robot is its programmable drug-dispensing system. Each of the robot’s four drug modules contains a different medication, which can be released in a controlled fashion using magnetic beams that vibrate at specific frequencies. These vibrations are triggered by an external magnetic field, which the medical team can adjust to determine the timing and sequence of drug release. This programmable control is particularly useful for combination therapies, where certain drugs need to be administered at precise intervals to maximize efficacy. For example, the robot could deliver a chemotherapy drug to a tumor site, followed by a drug that boosts the immune system’s response, in a sequence that mirrors the optimal treatment plan for cancer patients.
In a series of controlled experiments, the researchers demonstrated the robot’s capabilities. Placed in a liquid environment designed to mimic the conditions inside the human body, the robot successfully navigated its surroundings, moving to specific locations to dispense its drugs. The results showed that the robot could deliver its payload with minimal leakage – only 4.12 to 8.08 percent of the drugs were unintentionally released after eight hours of continuous operation. This precise control over drug release is essential in minimizing side effects, ensuring that medication reaches only the intended area without damaging surrounding tissues.
Technically, the robot’s drug-dispensing modules can release drugs at a rate of 0.0992 to 0.231 microliters per hour, depending on how the magnetic field is programmed. This level of precision ensures that each drug is delivered in the correct dose, making it ideal for therapies that require tight control over timing and dosage. The robot’s ability to selectively release its drugs, instead of dispensing all of them at once, marks a significant improvement over older systems that lack this level of control. This is particularly important for complex diseases like cancer, where treatment often involves multiple drugs with different mechanisms of action.
Biocompatibility is another critical consideration in the development of any medical device, and the researchers took steps to ensure that the materials used in the robot are safe for use in the human body. The robot is made from smart magnetic composites that were tested for cytotoxicity using human dermal fibroblast cells. The results showed that the materials did not cause significant cell death or damage, making them suitable for biological environments. This is a key step in moving toward clinical applications, as biocompatibility is essential for any device that will interact with human tissues.
The researchers also focused on the durability and reliability of the robot over extended periods of use. After eight hours of continuous movement and drug dispensing, the robot retained its functionality, with only minimal drug leakage. This robustness is crucial for long-term treatments, where the robot may need to remain inside the body for several hours or even days, delivering drugs as needed. The fact that the robot can maintain its structural integrity and drug-dispensing precision under these conditions speaks to the potential of this technology for future medical applications.
The implications of this research are broad. By enabling more controlled and precise drug delivery, this robot has the potential to transform how combination therapies are administered. In cancer treatment, for example, patients often receive multiple drugs, each designed to target different aspects of the disease. Currently, these drugs are administered separately, with significant risks of toxicity and side effects due to the imprecision of traditional delivery methods. This new robotic technology could streamline that process, allowing multiple drugs to be delivered directly to the tumor site in the exact sequence and dosage required, minimizing side effects and enhancing the overall effectiveness of the therapy.
The potential applications of this technology go beyond cancer treatment. The ability to program the robot to deliver multiple drugs in a controlled sequence could be applied to a wide range of medical conditions, from cardiovascular diseases to neurological disorders. For example, in cardiovascular treatments, the robot could be used to deliver clot-busting drugs directly to a blocked artery, followed by anti-inflammatory medications to reduce the risk of further complications. Similarly, in neurological treatments, the robot could precisely deliver drugs to specific areas of the brain, potentially improving outcomes for patients with conditions like Parkinson’s or epilepsy.
Looking to the future, the researchers are working to further miniaturize the robot to make it suitable for even more applications. They are also exploring the possibility of integrating real-time imaging techniques, such as ultrasound or MRI, to track the robot’s movements inside the body during treatment. This would allow doctors to monitor and adjust the robot’s position and drug delivery in real time, further improving the precision and effectiveness of the therapy.
Get our Nanotechnology Spotlight updates to your inbox!
Thank you!
You have successfully joined our subscriber list.
Become a Spotlight guest author! Join our large and growing group of guest contributors. Have you just published a scientific paper or have other exciting developments to share with the nanotechnology community? Here is how to publish on nanowerk.com.
